The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

About Argos Resources

Argos Resources is an oil and gas exploration company. It is based in Stanley, Falkland Islands.

Argos Resources Headquarter Location

Argos House H Jones Road

Stanley, FIQQ 1ZZ,

Falkland Islands (Malvinas)

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Argos Resources News

Goldplat rallies after extending share buyback

Apr 11, 2022

Goldplat rallies after extending share buyback A look at some of the major movers in London on Monday Goldplat PLC (AIM:GDP) jumped 18% to 8.1p on the back of news it’s extending its share buyback programme. After the AIM-listed Gold producer completed the purchase of its target of ordinary shares worth £198,940 on 8 April, it’s now extended the repurchase for up to a further total value of £200,000 at 1p per share. Its shares were traded at a significant discount to their intrinsic value, despite the strong operational and financial momentum of the business, the company’s board commented. “Share buybacks are an appropriate means of returning value whilst maximising sustainable long-term growth for shareholders, given the enhancement to net asset value, earnings and dividends per share that will result from reducing the number of shares in issue,” it said. 2.34pm: Argos Resources climbs after licence extension Argos Resources Ltd (LSE:ARG) surged 23% to 2.4p on news that the Falkland Islands government extended its second term PL001 licence. The Falklands Islands-based explorer will not need to commit to any additional work to be granted the licence between 1 May 2022 and the year end. Its shares skyrocketed 92% since the beginning of 2022. 1.34pm: Dekel Agri-Vision slumps on underwhelming March crude palm oil production Dekel Agri-Vision plc (AIM:DKL) fell 10% after providing an underwhelming update to its crude palm oil (CPO) March production levels. Ivory Coast’s high season, which usually peaks in March, was yet to begin resulting in CPO production being 50.5% below the same month last year. The West-African agricultural company also said it anticipates its April levels to be similar to that of this month. Although high prices and “excellent” CPO extraction rates mean this year’s first-quarter revenue remained ahead of Q1 2021. 12.34pm: Induction Healthcare surges after strong recurring business numbers Induction Healthcare Group PLC (AIM:INHC) surged 24% to 54p as its Attend Anywhere video platform sees high recurring business numbers. The technology enables patients to conduct consultations with doctors from anywhere, with 94% of its existing contracts with NHS England either renewed or extended. That translates to annual recurring revenue of £6.6mln in the upcoming financial year. New contracts are also locked in for up to three years rather than one, with the majority of renewals committing to at least two years, resulting in an aggregate contract value of £10.9mln. 11.36am: Bluejay Mining sinks on revised Greeland targets Bluejay Mining PLC sunk 16% after it revised its field programme expectations at the Disko-Nuussuaq project in Greenland. The joint venture (JV) with Nikkeli Greenland A/S, which was created by Bluejay and its JV partner KoBold Metals, was re-evaluated with the goal of doubling collection and analysis of modern data for all targets. The AIM, FSE-listed and OTCQB traded explorer and developer also intends to start diamond drilling in 2023. This additional work will allow the JV to determine the best drill targets at Disko, it said. 10.35am: Scancell rockets as it recruits patients for cancer trial Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) rocketed 30% to 13.9p after it began recruiting for its Modi-1 cancer trial, which expects to open up to 20 sites. The study is a first-in-human clinical trial in patients with triple-negative breast cancer, ovarian cancer, head and neck cancer, and renal cancer. Modi-1 will be administered alone and in combination with checkpoint inhibitors (CPIs) in patients where the CPI is the standard of care. As previously announced, the company expects early safety and immunogenicity data to be available in the second half of this year with potential efficacy data to follow in 2023. 9.05am: Amigo surges after positive response from FCA Amigo Holdings PLC (LSE:AMGO) soared 27% to 5.79p after updating on the schemes of arrangement to redress claims relating to historic loans. The Financial Conduct Authority (FCA) indicated it believed there had been a significant improvement in the fairness of the various schemes the loan guarantor is preparing. “There remain significant obstacles to overcome, including the need for a significantly dilutive equity issue, to recapitalise the ongoing business given the requirements of the schemes for the transfer of virtually all existing assets to the redress creditors," cautioned Gary Jennison, the chief executive officer of Amigo. Quadrise Fuels International PLC (AIM:QFI) leapt 22% to 2.4p as it announced a commercial development with Valkor Technologies. Under phase one of the commercial development agreement, Valkor will deliver a crude oil sample from a heavy oil asset in Utah in which they have an existing equity interest to Quadrise. Quadrise will perform analysis and testing on the sample to confirm that it is suitable to produce the company’s MSAR and bioMSAR formulation. Both companies will negotiate supply agreements with identified target consumers of MSAR and bioMSAR fuel to be produced by the primary project. Add related topics to MyProactive

  • Where is Argos Resources's headquarters?

    Argos Resources's headquarters is located at Argos House, Stanley.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.